Velocity Pharmaceutical Development Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Employees
-
8
- Latest Deal Type
-
Out of Business
Velocity Pharmaceutical Development General Information
Description
Provider of drug development services intended to design and execute the clinical development program for each new drug candidate. The company's services include controlling purchases of drug candidates and to develop these candidates using a cost-efficient model by investing in their development through clinical proof-of-concept, enabling biotechnology companies, pharmaceutical companies and academia to achieve the funding needed to take the drug candidate to clinical proof-of-concept while accessing a world-class team to design and manage the development program.
Contact Information
Website
www.vpd.netCorporate Office
- 400 Oyster Point Boulevard
- Suite 202
- South San Francisco, CA 94080
- United States
Corporate Office
- 400 Oyster Point Boulevard
- Suite 202
- South San Francisco, CA 94080
- United States
Velocity Pharmaceutical Development Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 29-Nov-2022 | Completed | Out of Business | |||
| 1. Seed Round | 01-Jan-2011 | Completed | Startup |
Velocity Pharmaceutical Development Comparisons
Industry
Financing
Details
Velocity Pharmaceutical Development Competitors (5)
One of Velocity Pharmaceutical Development’s 5 competitors is Talphera, a Formerly VC-backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Talphera | Formerly VC-backed | San Mateo, CA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| AbbVie | Corporation | North Chicago, IL |
Velocity Pharmaceutical Development Signals
Velocity Pharmaceutical Development Investments (2)
Velocity Pharmaceutical Development’s most recent deal was a Joint Venture with Vitesse Biologics. The deal was made on 01-Jun-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vitesse Biologics | 01-Jun-2015 | Joint Venture | Biotechnology | ||
| VYNE Therapeutics | 19-Aug-2013 | Early Stage VC | Drug Discovery |
Velocity Pharmaceutical Development FAQs
-
When was Velocity Pharmaceutical Development founded?
Velocity Pharmaceutical Development was founded in 2011.
-
Where is Velocity Pharmaceutical Development headquartered?
Velocity Pharmaceutical Development is headquartered in South San Francisco, CA.
-
What is the size of Velocity Pharmaceutical Development?
Velocity Pharmaceutical Development has 8 total employees.
-
What industry is Velocity Pharmaceutical Development in?
Velocity Pharmaceutical Development’s primary industry is Biotechnology.
-
Is Velocity Pharmaceutical Development a private or public company?
Velocity Pharmaceutical Development is a Private company.
-
What is Velocity Pharmaceutical Development’s current revenue?
The current revenue for Velocity Pharmaceutical Development is .
-
Who are Velocity Pharmaceutical Development’s competitors?
Talphera, Bristol-Myers Squibb, Genentech, Merck & Co., and AbbVie are competitors of Velocity Pharmaceutical Development.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process